0001127602-13-011723.txt : 20130321 0001127602-13-011723.hdr.sgml : 20130321 20130321180512 ACCESSION NUMBER: 0001127602-13-011723 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130320 FILED AS OF DATE: 20130321 DATE AS OF CHANGE: 20130321 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Pugh Gordon G CENTRAL INDEX KEY: 0001376545 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35299 FILM NUMBER: 13708636 MAIL ADDRESS: STREET 1: 88 SIDNEY ST CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Alkermes plc. CENTRAL INDEX KEY: 0001520262 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 981007018 FISCAL YEAR END: 0331 BUSINESS ADDRESS: STREET 1: TREASURY BUILDING STREET 2: LOWER GRAND CANAL STREET CITY: DUBLIN 2 STATE: L2 ZIP: 00000 BUSINESS PHONE: 00-353-1-649-2000 MAIL ADDRESS: STREET 1: TREASURY BUILDING STREET 2: LOWER GRAND CANAL STREET CITY: DUBLIN 2 STATE: L2 ZIP: 00000 FORMER COMPANY: FORMER CONFORMED NAME: ANTLER SCIENCE TWO PLC DATE OF NAME CHANGE: 20110804 FORMER COMPANY: FORMER CONFORMED NAME: Antler Science Two Ltd DATE OF NAME CHANGE: 20110509 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2013-03-20 0001520262 Alkermes plc. ALKS 0001376545 Pugh Gordon G 852 WINTER ST. WALTHAM MA 02451 1 SVP, COO & CRO, Alkermes, Inc. Ordinary Shares 2013-03-20 4 M 0 18747 8.55 A 28580 D Ordinary Shares 2013-03-20 4 S 0 18747 22.7481 D 9833 D Ordinary Shares 5000 I Gordon G. Pugh Revocable Trust - 2012 Ordinary Shares 15000 I Nancy E. Pugh Revocable Trust - 2012 Employee Stock Option (Right to Buy) 8.55 2013-03-20 4 M 0 18747 0 D 2019-05-26 Ordinary Shares 18747 16253 D This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $22.61 to $22.88. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. 75% vested, remaining 25% vests on 5/26/13. /s/ Jennifer Baptiste, attorney-in-fact for Gordon G. Pugh 2013-03-21